| | | | | | What you need to know about the coronavirus today | ‘Delivering hope’ to millions Cargo planes and trucks with the first U.S. shipments of coronavirus vaccine fanned out from FedEx and UPS hubs in Tennessee and Kentucky on Sunday en route to distribution points around the country, launching an immunization project of unprecedented scope and complexity.
Governor Andy Beshear of Kentucky suggested the very first injections of the vaccine will be given in his state, home to the UPS Worldport sorting facility in Louisville - one of two distribution command centers. The other is the FedEx air cargo hub in Memphis, Tennessee.
“Today, we’re not hauling freight, we’re delivering hope,” said Andrew Boyle, co-president of Boyle Transportation, which was hired by UPS to help ferry vaccine.
COVID-19 infections are still rising in 71 countries. There have been at least 71,379,000 reported infections and 1,610,000 reported deaths caused by the new coronavirus so far. | | | | | | Asian leaders find support sliding Japan and South Korea grappled with surging cases and growing public frustration, with Japan suspending a contentious travel subsidy program and South Korea closing some schools and considering its toughest curbs yet. Prime Minister Yoshihide Suga had ruled out halting the program, citing economic considerations, but that changed after weekend polls showed his support being eroded over his handling of the pandemic.
Germany to stay in lockdown Germany is unlikely to lift its lockdown early next year, a top aide to Chancellor Angela Merkel said, signaling Europe’s biggest economy will have to contend with the crippling restrictions well into the winter months. Merkel and German state leaders agreed to shut most stores from Wednesday until Jan. 10 to reverse a tide of infections that lighter restrictions introduced last month had failed to tame.
New Zealand agrees on ‘travel bubble’ with Australia New Zealand agreed to allow quarantine-free travel with Australia in the first quarter of 2021, nearly a year after it locked down its borders in response to the COVID-19 pandemic. Prime Minister Jacinda Ardern said the cabinet had agreed in principle on a trans-Tasman, quarantine-free travel bubble pending confirmation by Australia’s cabinet and no significant change in circumstances in either country.
Single-patient study adds to debate over remdesivir A single-patient study conducted by British scientists has found that Gilead’s antiviral drug remdesivir could be highly effective against COVID-19, raising questions about previous studies that found it had no impact on death rates from the disease. The study describes how doctors who gave the drug to a patient with both COVID-19 and a rare immune disorder saw a marked improvement in his symptoms and the disappearance of the virus. | | | | From Breakingviews - Corona Capital: F1 injection, China exports, Mink. Lossmaking supercar maker McLaren has pulled over for a much-needed pit stop, and the pandemic has saddled some luxury fashion houses with a supply chain dilemma. Catch up with the latest financial insights. | | | | Reuters reporters and editors around the world are investigating the response to the coronavirus pandemic.
We need your help to tell these stories. Our news organization wants to capture the full scope of what’s happening and how we got here by drawing on a wide variety of sources.
Are you a government employee or contractor involved in coronavirus testing or the wider public health response? Are you a doctor, nurse or health worker caring for patients? Have you worked on similar outbreaks in the past? Has the disease known as COVID-19 personally affected you or your family? Are you aware of new problems that are about to emerge, such as critical supply shortages?
We need your tips, firsthand accounts, relevant documents or expert knowledge. Please contact us at coronavirus@reuters.com.
We prefer tips from named sources, but if you’d rather remain anonymous, you can submit a confidential news tip. Here’s how. | | | | | | | | | | | Top Stories on Reuters TV | | | | | | | |